4//SEC Filing
LEPORE PATRICK G 4
Accession 0001209191-23-020480
CIK 0001566044other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:03 PM ET
Size
5.5 KB
Accession
0001209191-23-020480
Insider Transaction Report
Form 4
LEPORE PATRICK G
Director
Transactions
- Purchase
Common Stock
2023-03-20$2.48/sh+20,000$49,680→ 23,472 total
Footnotes (2)
- [F1]The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001055404
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:03 PM ET
- Size
- 5.5 KB